Amelioration of Insulin Requirement in Patients Undergoing Duodenal Bypass for Reasons Other than Obesity Implicates Foregut Factors in the Pathophysiology of Type II Diabetes

被引:35
作者
Zervos, Emmanuel E. [1 ]
Agle, Steven C. [1 ]
Warren, Alex J. [1 ]
Lang, Christina G. [1 ]
Fitzgerald, Timothy L. [1 ]
Dar, Moahad [2 ,3 ]
Rotondo, Michael F. [1 ]
Pories, Walter J. [1 ,2 ]
机构
[1] E Carolina Univ, Dept Surg, Div Surg Oncol, Greenville, NC USA
[2] E Carolina Univ, Metab Inst, Greenville, NC USA
[3] E Carolina Univ, Dept Internal Med, Div Endocrinol & Metab, Greenville, NC USA
关键词
Y GASTRIC BYPASS; LAPAROSCOPIC TREATMENT; MELLITUS; BURDEN;
D O I
10.1016/j.jamcollsurg.2009.12.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Foregut diversion and weight loss have been proposed as potential mechanisms for resolution of type II diabetes mellitus (T2DM) observed in patients undergoing gastric bypass for obesity. To support or refute the role of the foregut, we analyzed glycemic control in T2DM patients before and after foregut bypass for reasons other than morbid obesity. STUDY DESIGN: Using ICD9/CPT codes, we identified patients undergoing Roux-en-Y gastrojejunostomy (RY) or Billroth II (BII) reconstruction over 10 years. Fasting blood glucose, insulin or oral diabetic agent requirement, and body mass index (BMI) before and after surgery were tabulated and compared using the Student's t-test. Linear regression was applied to determine specific factors predictive of resolution or improvement in glycemic control including age, duration of diabetes, antidiabetic regimen, type of operation, and surgical indication. RESULTS: Between 1996 and 2006, we identified 24 patients with T2DM out of a cohort of 209 who underwent either RY (12 of 24) or BII reconstruction (12 of 24) for cancer or peptic ulcer disease and survived more than 30 days after operation. Of this group, 75% were overweight (18 of 24 with BMI < 30 kg/m(2)) and 25% were class I morbidly obese (6 of 24 with BMI 30 to 35 kg/m(2)). Seventeen patients (71%) had either complete resolution (7 of 24 or 29%) or significant reduction (10 of 24 or 42%) in medication requirements; 7 patients (29%) did not have any improvement. Logistic regression failed to identify specific factors predicting improved glycemic control. CONCLUSIONS: Complete resolution of T2DM in patients undergoing duodenal diverting surgery occurs in about one-third of nonobese patients. Improved glycemic control occurs in more than two-thirds and cannot be explained by surgically related weight loss alone. Surgical cure of T2DM may be possible in carefully selected nonobese patients. (J Am Coll Surg 2010;210:564-574. (C) 2010 by the American College of Surgeons)
引用
收藏
页码:564 / 572
页数:9
相关论文
共 22 条
  • [1] [Anonymous], 2007, NAT DIAB FACT SHEET
  • [2] BUCHWALD E, 2009, AM J MED, V122
  • [3] Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35
    DePaula, A. L.
    Macedo, A. L. V.
    Rassi, N.
    Machado, C. A.
    Schraibman, V.
    Silva, L. Q.
    Halpern, A.
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2008, 22 (03): : 706 - 716
  • [4] Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus
    DePaula, A. L.
    Macedo, A. L. V.
    Rassi, N.
    Vencio, S.
    Machado, C. A.
    Mota, B. R.
    Silva, L. Q.
    Halpern, A.
    Schraibman, V.
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2008, 22 (12): : 2670 - 2678
  • [5] Surgery for Nonobese Type 2 Diabetic Patients: An Interventional Study with Duodenal-Jejunal Exclusion
    Geloneze, Bruno
    Geloneze, Sylka R.
    Fiori, Carla
    Stabe, Christiane
    Tambascia, Marcos A.
    Chaim, Elinton A.
    Astiarraga, Brenno D.
    Pareja, Jose Carlos
    [J]. OBESITY SURGERY, 2009, 19 (08) : 1077 - 1083
  • [6] Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss
    Kadera, Brian E.
    Lum, Kristian
    Grant, John
    Pryor, Aurora D.
    Portenier, Dana D.
    DeMaria, Eric J.
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (03) : 305 - 309
  • [7] Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus:: Comparison of BMI &gt;35 and &lt;35 kg/m2
    Lee, Wei-Jei
    Wang, Weu
    Lee, Yi-Chih
    Huang, Ming-Te
    Ser, Kong-Han
    Chen, Jung-Chien
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (05) : 945 - 952
  • [8] The Gastric Bypass Operation Reduces the Progression and Mortality of Non-Insulin-Dependent Diabetes Mellitus
    MacDonald Jr. K.G.
    Long S.D.
    Swanson M.S.
    Brown B.M.
    Morris P.
    Dohm G.L.
    Pories W.J.
    [J]. Journal of Gastrointestinal Surgery, 1997, 1 (3) : 213 - 220
  • [9] Meta-analysis: Surgical treatment of obesity
    Maggard, MA
    Shugarman, LR
    Suttorp, M
    Maglione, M
    Sugarman, HJ
    Livingston, EH
    Nguyen, NT
    Li, ZP
    Mojica, WA
    Hilton, L
    Rhodes, S
    Morton, SC
    Shekelle, PG
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (07) : 547 - 559
  • [10] Role of the incretin system in the remission of type 2 diabetes following bariatric surgery
    Mingrone, G.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (08) : 574 - 579